Pharming Group to Present at Canaccord Genuity Growth Conference
Event summary
- Pharming Group N.V. to participate in Canaccord Genuity's 46th Annual Growth Conference on August 12-13, 2026.
- Michael Levitan, VP Investor Relations and Capital Markets, will lead a Fireside Chat Q&A session on August 12 at 10:00 EDT/16:00 CEST.
- One-on-one meetings with Pharming’s management team available upon request.
The big picture
Pharming's participation in a high-profile investor conference underscores its focus on engaging with capital markets amid a challenging biotech funding environment. The event provides an opportunity to showcase its pipeline of innovative medicines targeting rare diseases, a segment that continues to attract significant interest despite broader market headwinds.
What we're watching
- Investor Sentiment
- How Pharming's presentation will impact investor confidence amid broader biotech sector volatility.
- Strategic Messaging
- Whether the company will provide updates on pipeline progress or commercialization milestones during the conference.
- Competitive Positioning
- The pace at which Pharming can differentiate itself in the crowded rare disease therapeutics market.